Progeneer Looks To Disrupt Cell-Free Protein Synthesis Landscape

Individualized Oncovaccine Against BCL

 
• By Jung Won Shin
  
Chul Kim, CEO of Progeneer
Progeneer wants to provide solutions to certain 'mislinks' in new drug development • Source: Progeneer Inc.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia